{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:08Z","timestamp":1792783268420,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fujian Medical University's \"Sailing Project 2022\"","award":["No. 2022QH1135"],"award-info":[{"award-number":["No. 2022QH1135"]}],"id":[{"id":"https:\/\/ror.org\/050s6ns64","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05195-0","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:16:58Z","timestamp":1778869018000},"page":"5005-5013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic changes in FGF-21 and their association with inflammation and pulmonary function in ESRD patients undergoing peritoneal dialysis: a prospective cohort study"],"prefix":"10.1007","volume":"58","author":[{"given":"Changda","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishuang","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"8","key":"5195_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.034176","volume":"13","author":"TW Kao","year":"2024","unstructured":"Kao TW, Chen ZW, Lin YH (2024) Anticoagulation for patients with concomitant atrial fibrillation and end-stage renal disease: a systematic review and network meta-analysis. J Am Heart Assoc 13(8):e034176","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"5195_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000514550","volume":"52","author":"JS Thurlow","year":"2021","unstructured":"Thurlow JS et al (2021) Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol 52(2):98\u2013107","journal-title":"Am J Nephrol"},{"issue":"6","key":"5195_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1053\/j.ajkd.2019.12.005","volume":"75","author":"CP Walther","year":"2020","unstructured":"Walther CP et al (2020) Diagnosis and management of pulmonary hypertension in patients with CKD. Am J Kidney Dis 75(6):935\u2013945","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"5195_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41581-024-00857-7","volume":"20","author":"K Zeder","year":"2024","unstructured":"Zeder K et al (2024) Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes. Nat Rev Nephrol 20(11):742\u2013754","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"5195_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195585","volume":"13","author":"H Mukai","year":"2018","unstructured":"Mukai H et al (2018) Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease. PLoS ONE 13(4):e0195585","journal-title":"PLoS ONE"},{"issue":"2","key":"5195_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/jpm13020286","volume":"13","author":"G Gembillo","year":"2023","unstructured":"Gembillo G et al (2023) Lung dysfunction and chronic kidney disease: a complex network of multiple interactions. J Pers Med 13(2):286","journal-title":"J Pers Med"},{"key":"5195_CR7","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.12659\/MSM.897480","volume":"22","author":"S Y\u0131lmaz","year":"2016","unstructured":"Y\u0131lmaz S et al (2016) Pulmonary function in patients with end-stage renal disease: effects of hemodialysis and fluid overload. Med Sci Monit 22:2779\u20132784","journal-title":"Med Sci Monit"},{"key":"5195_CR8","doi-asserted-by":"publisher","first-page":"154738","DOI":"10.1016\/j.metabol.2021.154738","volume":"118","author":"JV Salgado","year":"2021","unstructured":"Salgado JV, Goes MA, Salgado Filho N (2021) FGF21 and chronic kidney disease. Metab 118:154738","journal-title":"Metab"},{"issue":"11","key":"5195_CR9","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.metabol.2010.03.018","volume":"59","author":"SH Han","year":"2010","unstructured":"Han SH et al (2010) Serum fibroblast growth factor\u201321 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. Metab 59(11):1656\u20131662","journal-title":"Metab"},{"issue":"4","key":"5195_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018398","volume":"6","author":"Z Lin","year":"2011","unstructured":"Lin Z et al (2011) Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese. PLoS ONE 6(4):e18398","journal-title":"PLoS ONE"},{"key":"5195_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/20420188211001160","volume":"12","author":"MA Gomez-Samano","year":"2021","unstructured":"Gomez-Samano MA et al (2021) Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease. Ther Adv Endocrinol Metab 12:20420188211001160","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"5195_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151698","volume":"11","author":"E Gonz\u00e1lez","year":"2016","unstructured":"Gonz\u00e1lez E et al (2016) Fibroblast growth factor 21 (FGF-21) in peritoneal dialysis patients: natural history and metabolic implications. PLoS ONE 11(3):e0151698","journal-title":"PLoS ONE"},{"issue":"6","key":"5195_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178971","volume":"12","author":"M Kohara","year":"2017","unstructured":"Kohara M et al (2017) Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease. PLoS ONE 12(6):e0178971","journal-title":"PLoS ONE"},{"issue":"1","key":"5195_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-023-04488-5","volume":"27","author":"P Ding","year":"2023","unstructured":"Ding P et al (2023) Fibroblast growth factor 21 attenuates ventilator-induced lung injury by inhibiting the NLRP3\/caspase-1\/GSDMD pyroptotic pathway. Crit Care 27(1):196","journal-title":"Crit Care"},{"key":"5195_CR15","doi-asserted-by":"publisher","first-page":"764503","DOI":"10.3389\/fphys.2021.764503","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou X, Zhang Y, Wang N (2021) Regulation and potential biological role of fibroblast growth factor 21 in chronic kidney disease. Front Physiol 12:764503","journal-title":"Front Physiol"},{"issue":"1","key":"5195_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202009-3533SO","volume":"203","author":"DMG Halpin","year":"2021","unstructured":"Halpin DMG et al (2021) Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 203(1):24\u201336","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"5195_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10875-021-00974-z","volume":"41","author":"ML Fr\u00e9mond","year":"2021","unstructured":"Fr\u00e9mond ML, Crow YJ (2021) STING-mediated lung inflammation and beyond. J Clin Immunol 41(3):501\u2013514","journal-title":"J Clin Immunol"},{"issue":"10","key":"5195_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S2352-4642(22)00185-7","volume":"6","author":"J Reyes-Angel","year":"2022","unstructured":"Reyes-Angel J et al (2022) Obesity-related asthma in children and adolescents. Lancet Child Adolesc Health 6(10):713\u2013724","journal-title":"Lancet Child Adolesc Health"},{"issue":"8","key":"5195_CR19","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL et al (2019) Standardization of spirometry 2019 update. An official American Thoracic Society and European respiratory society technical statement. Am J Respir Crit Care Med 200(8):e70\u2013e88","journal-title":"Am J Respir Crit Care Med"},{"key":"5195_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/20420188211001160","volume":"12","author":"M G\u00f3mez-S\u00e1mano","year":"2021","unstructured":"G\u00f3mez-S\u00e1mano M et al (2021) Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease. Ther Adv Endocrinol Metab 12:20420188211001160","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"11","key":"5195_CR21","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.metabol.2010.03.018","volume":"59","author":"SH Han","year":"2010","unstructured":"Han SH et al (2010) Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. Metab 59(11):1656\u20131662","journal-title":"Metab"},{"issue":"23","key":"5195_CR22","doi-asserted-by":"publisher","first-page":"12838","DOI":"10.3390\/ijms252312838","volume":"25","author":"N Carullo","year":"2024","unstructured":"Carullo N et al (2024) Anemia and mineral bone disorder in kidney disease patients: the role of FGF-23 and other related factors. Int J Mol Sci 25(23):12838","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5195_CR23","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s10753-024-02032-3","volume":"47","author":"LQ Cai","year":"2024","unstructured":"Cai LQ et al (2024) Investigation of metabolic and inflammatory disorder in the aging FGF21 knockout mouse. Inflamm 47(6):2173\u20132195","journal-title":"Inflamm"},{"issue":"7","key":"5195_CR24","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.7150\/thno.55795","volume":"11","author":"F Wang","year":"2021","unstructured":"Wang F et al (2021) Organ-organ communication: the liver\u2019s perspective. Theranostics 11(7):3317\u20133330","journal-title":"Theranostics"},{"key":"5195_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.108291","volume":"247","author":"S Chander","year":"2025","unstructured":"Chander S et al (2025) The effect of kidney replacement therapy on lung mechanics and respiratory function: a systematic review and meta-analysis. Respir Med 247:108291","journal-title":"Respir Med"},{"key":"5195_CR26","doi-asserted-by":"publisher","first-page":"1372079","DOI":"10.3389\/fimmu.2024.1372079","volume":"15","author":"AM Valdes","year":"2024","unstructured":"Valdes AM et al (2024) Preoperative inflammatory biomarkers reveal renal involvement in postsurgical mortality in hip fracture patients: an exploratory study. Front Immunol 15:1372079","journal-title":"Front Immunol"},{"issue":"2","key":"5195_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017148","volume":"6","author":"W Van Biesen","year":"2011","unstructured":"Van Biesen W et al (2011) Fluid status in peritoneal dialysis patients: the European body composition monitoring (EuroBCM) study cohort. PLoS ONE 6(2):e17148","journal-title":"PLoS ONE"},{"issue":"1","key":"5195_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2179336","volume":"45","author":"G Yong","year":"2023","unstructured":"Yong G, Li L, Hu S (2023) Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis. Ren Fail 45(1):2179336","journal-title":"Ren Fail"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05195-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05195-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05195-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:17:09Z","timestamp":1792765029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05195-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["5195"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05195-0","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of The Second Affiliated Hospital of Fujian Medical University (approval number: [2020] No. (146)). All participants provided written informed consent prior to enrollment.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}